Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Lupus Nephritis Market Size, Value And Growth Trends Through 2030

The lupus nephritis market experienced robust expansion recently, projecting a rise from $2.08 billion in 2025 to $2.24 billion in 2026, reflecting a compound annual growth rate of 7.7%. This historical growth trajectory was fueled by several key factors, including the escalating incidence of systemic lupus erythematosus, advancements in kidney biopsy and diagnostic methods, the extensive application of corticosteroids for treatment, the expanding availability of hospital-based nephrology services, and heightened public understanding of autoimmune kidney disorders.

The lupus nephritis market is poised for significant expansion, projecting a reach of $2.98 billion by 2030 with a compound annual growth rate (CAGR) of 7.4%. This anticipated growth over the forecast period is fueled by several key factors, including increased funding for biologic drug research, a greater emphasis on early intervention strategies to avert kidney damage, the wider acceptance of combined treatment approaches, the proliferation of specialized kidney care centers, and escalating healthcare expenditures dedicated to managing autoimmune conditions. Key developments shaping this market include a heightened focus on prompt diagnosis and continuous patient monitoring, the increasing utilization of immunosuppressive and biologic treatments, a growing inclination towards tailored therapeutic plans, the development of more comprehensive long-term disease management frameworks, and elevated public and professional awareness regarding autoimmune kidney afflictions.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22044&type=smp

Lupus Nephritis Market Growth Drivers: What Factors Are Accelerating Expansion?

An upward trend in the incidence of genetic predisposition is anticipated to fuel the expansion of the lupus nephritis market. This inherent genetic susceptibility means individuals possess inherited characteristics that heighten their risk for specific ailments. The rise in such predispositions stems from a combination of inherited factors, external environmental impacts, and alterations

Lupus Nephritis Market Categorization By Product Type And Application

The lupus nephritis market covered in this report is segmented –

1) By Stage: Class 1, Class 2, Class 3, Other Stages

2) By Drug Class: Immunosuppressive Drugs, Corticosteroids, Biological Agents, Antimalarial Drugs

3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

5) By End-User: Hospitals, Specialty Clinics, Other End-Users

Subsegments:

1) By Class 1: Asymptomatic Cases, Mild Proteinuria, Incidental Diagnosis

2) By Class 2: Mild Hematuria, Low-Grade Proteinuria, Minimal Immune Complex Deposition

3) By Class 3: Active Lesions, Chronic Sclerotic Lesions, Crescent Formation

4) By Other Stages: Class 4 (Diffuse Lupus Nephritis), Class 5 (Membranous Lupus Nephritis), Class 6 (Advanced Sclerotic Lupus Nephritis)

Lupus Nephritis Market Trends: What Is Shaping Future Industry Growth?

Key players within the lupus nephritis sector are prioritizing the innovation of sophisticated second-generation calcineurin inhibitors aimed at boosting therapeutic effectiveness and fostering better long-term kidney health for individuals afflicted with the condition. These advanced calcineurin inhibitors serve to mitigate inflammation and avert renal deterioration in lupus nephritis by regulating the body’s immune responses. A notable development occurred in September of 2024 when Aurinia Pharmaceuticals Inc., a biopharmaceutical firm headquartered in Canada that is currently in its commercial stage, revealed that LUPKYNIS, also known as voclosporin, received endorsement from the Japanese Ministry of Health, Labour, and Welfare for the management of lupus nephritis. This regulatory clearance permits the utilization of voclosporin alongside mycophenolate mofetil (MMF), a recommendation stemming from the findings of the AURORA Clinical Program, which substantiated its safety profile and beneficial effects, thereby representing a pivotal advancement in broadening the therapeutic choices available to lupus nephritis sufferers in Japan and consequently enhancing both disease control and patient prognoses.

Lupus Nephritis Market Company Landscape And Strategic Competition

Major companies operating in the lupus nephritis market are F Hoffmann La Roche Ltd, Bristol Myers Squibb, Novartis AG, GlaxoSmithKline plc, Eli Lilly and Company, AstraZeneca PLC, Pfizer Inc, Johnson and Johnson, Merck and Co Inc, Sanofi, AbbVie Inc, Bayer AG, Amgen Inc, UCB SA, Otsuka Pharmaceutical Co Ltd, Aurinia Pharmaceuticals Inc, RemeGen Co Ltd, Kezar Life Sciences, Equillium Inc, Kyverna Therapeutics Inc, Biogen Inc

Access The Complete Lupus Nephritis Market Report:

https://www.thebusinessresearchcompany.com/report/lupus-nephritis-global-market-report

Lupus Nephritis Market Geographic Distribution And Regional Opportunities

Asia-Pacificwas the largest region in the lupus nephritis market in 2025. The regions covered in the lupus nephritis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model